Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple Sclerosis
A Randomized, Double-blind, Placebo-controlled, Parallel-Group, Dose-Ranging Study to Investigate the MRI Efficacy and Safety of Six Months' Administration of Ofatumumab in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) A Randomized, Double-blind, Placebo-controlled, Parallel-Group, Dose-Ranging Study to Investigate th ...
United States;Bulgaria;Canada;Czechia;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;Czech Republic United States;Bulgaria;Canada;Czechia;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Sp ...